Skip to main content

Diabetes

  • FDA panel recommends approval for two Novo Nordisk insulin products

    BAGSVÆRD, Denmark — A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

    Novo Nordisk said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had voted 8-to-4 in favor of approval for insulin degludec and a combination treatment containing insulin degludec and insulin aspart.

  • MinuteClinic offers free diabetes screenings in November

    WOONSOCKET, R.I. — MinuteClinic is offering free diabetes screenings during November to mark Diabetes Month.

  • mHealth transforming health care with apps

    Whatever dazzling visions science fiction may offer of the widgets of the future, the long, uphill road of technology inevitably leads to the smaller and the simpler. The horse and carriage gave way to the automobile; vacuum tubes gave way to transistors; and computers that took up entire rooms and required intricate climate-control technologies now fit in one’s pocket. 


    Technologies used in health care have undergone a similar transition, and much of that has happened in the last few years thanks to the spread of mobile technology. 


  • Rite Aid marks American Diabetes Month with Wellness+, Wellness store programs

    CAMP HILL, Pa. — Rite Aid is renewing its diabetes extension for Wellness+ and offering free screenings at all of its Wellness stores to mark American Diabetes Month, the retail pharmacy chain said Monday.

  • Taming the diabetes dragon: Pharmacists as front-line warriors for wellness

    Here’s a chilling statistic to ponder: Every 24 hours, more than 4,000 adults in the United States are diagnosed with diabetes, and some 200 die from its effects. That’s according to the Centers for Disease Control and Prevention, which also reports that diabetes afflicts roughly 26 million Americans and could eventually develop in another 79 million U.S. residents considered to have prediabetes.

  • Lilly to expand Indianapolis insulin factory

    INDIANAPOLIS – Eli Lilly is spending $140 million to expand its insulin manufacturing plant in Indianapolis, the drug maker said.

    Lilly said it would expand the plant by 80,000 sq. ft., saying it represented one of the most significant investments in its U.S. manufacturing operations in the past decade. Construction is expected to start immediately, with completion planned for March 2014.

  • Survey: Majority of Americans well aware of diabetes and corresponding risk factors

    MINNETONKA, Minn. — A majority of Americans recognize the threat diabetes poses to the nation’s health and have a solid understanding about the disease and its consequences, according to a new survey from UnitedHealth Group released Thursday. 

  • CVS/pharmacy, American Diabetes Association sponsor diabetes campaign

    WOONSOCKET, R.I. — CVS/pharmacy has announced that it is partnering with the American Diabetes Association as the sponsor of "A Day in the Life of Diabetes" campaign — a photo-sharing campaign on the ADA's main Facebook page.

    The CVS/pharmacy ExtraCare Advantage for Diabetes program will donate $1 to the American Diabetes Association for every photo or image uploaded, up to $25,000. CVS/pharmacy will also co-host a Twitter chat on Nov. 15 with Dr. Elizabeth Seaquist, VP medicine and science for the ADA.

X
This ad will auto-close in 10 seconds